Moderna’s mRNA RSV Vaccine Effective in Older Adults
Moderna’s mRNA-based RSV vaccine was effective at preventing RSV-associated lower respiratory tract disease in adults ages 60 and older, according to results of the randomized ConquerRSV trial. The mRNA-1345 vaccine was 83.7% effective (95.88% CI 66%-92.2%) in preventing RSV-associated lower respiratory tract disease with at least two signs or symptoms, and similarly effective (82.4%) against […]
The Case for a Yearly COVID Booster Shot
BOSTON — A yearly booster with an mRNA-based COVID vaccine may provide the best protection against catching the pandemic disease, a new analysis of the phase III COVE trial suggested. “Interestingly, we found that the longer duration between boosting actually provides better protection against COVID-19,” Dean Follmann, PhD, of the National Institute of Allergy and […]
Allergies to mRNA-based COVID-19 vaccines rare, generally mild, study finds
Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine. The findings will be published online Sept. 17 in JAMA Network Open. “We wanted to understand the spectrum of allergies to the […]